Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT

Long-Term Evolocumab in Patients With Familial Hypercholesterolemia

(2020) Raul D. Santos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study

(2020) Stephen Daniels et al.   Journal of Clinical Lipidology

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia

(2020) Raul D. Santos et al.   NEW ENGLAND JOURNAL OF MEDICINE

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Long-Term Efficacy and Safety of Evolocumab in Patients With Hypercholesterolemia

(2019) Michael J. Koren et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia

(2019) Ilse K. Luirink et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries

(2019) Uma Ramaswami et al.   ATHEROSCLEROSIS

Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register

(2018) S.E. Humphries et al.   ATHEROSCLEROSIS

Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT study

(2018) Daniel Gaudet et al.   Journal of Clinical Lipidology

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

(2017) Marc S. Sabatine et al.   NEW ENGLAND JOURNAL OF MEDICINE

Familial hypercholesterolaemia

(2017) Joep C. Defesche et al.   Nature Reviews Disease Primers

Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel

(2016) Raul D Santos et al.   Lancet Diabetes & Endocrinology

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

(2015) Albert Wiegman et al.   EUROPEAN HEART JOURNAL